Prevalence and risk factors of anti-tuberculosis drug-induced hepatitis in Malaysia
Tuberculosis (TB) affects onethird of the world’s population. Anti-TB drugs with isoniazid, rifampicin and pyrazinamide are very effective but they can cause hepatotoxicity. Many risk factors have been recognised. Data on prevalence of anti-TB drug-induced hepatitis as well as the contributing...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Singapore Medical Association
2008
|
| Subjects: | |
| Online Access: | http://irep.iium.edu.my/5027/1/prevalance_and_risk_factor.pdf http://irep.iium.edu.my/5027/ http://smj.sma.org.sg/4909/4909a5.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Tuberculosis (TB) affects onethird
of the world’s population. Anti-TB drugs
with isoniazid, rifampicin and pyrazinamide are
very effective but they can cause hepatotoxicity.
Many risk factors have been recognised. Data on
prevalence of anti-TB drug-induced hepatitis as
well as the contributing risk factors are scarce in
Malaysia. This observational case control study
was designed to look at the prevalence and the
risk factors of drug-induced hepatitis in our
population.
|
|---|